Top Story

AACI appoints new board members

August 22, 2014

Stanton L. Gerson, MD, Patrick J. Loehrer, Sr., MD, and Thomas A. Sellers, PhD, MPH, have been elected to the Association of American Cancer Institutes’ board of directors.

Elected as vice-president/president-elect, Gerson is the current director of the NCI-designated Case Comprehensive Cancer Center and founding director of the National Center for Regenerative Medicine. He also serves as director of University Hospitals Seidman Cancer Center as well as a member of the NCI Board of Scientific Advisors.

Patient-centered medical home program decreased hospital use, lowered care costs

August 22, 2014
In the 3 years since its introduction, CareFirst Blue Cross Blue Shield’s Patient-Centered Medical Home model has resulted in reduced hospital utilization, lower…
In the Journals

Tumor stage after neoadjuvant chemotherapy predicted post-surgery survival in esophageal adenocarcinoma

August 22, 2014
Tumor stage after neoadjuvant chemotherapy determined how long patients with esophageal and esophagogastric junction adenocarcinoma survived after surgery, according to…
In the Journals

Prior emphysema, chronic bronchitis linked to increased risk for lung cancer

August 22, 2014
Individuals who were previously diagnosed with chronic bronchitis or emphysema appear to be at increased risk for developing lung cancer, according to study…
More News Headlines »

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates

This activity is supported by an educational grant from Merck & Co., Inc.

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »
Meeting News Coverage Video

Docetaxel plus ADT improved OS in metastatic prostate cancer

June 24, 2014
CHICAGO — Donald L. Trump, MD, FACP, president and CEO at Roswell Park Cancer Institute and HemOnc Today
More »

Treatment Decision-Making through the Spectrum of MDS: Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »